Overview

Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine

Status:
Unknown status
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
Randomized controlled prospective comparative study
Phase:
Phase 1
Details
Lead Sponsor:
University College Hospital, Ibadan
Treatments:
Fanasil, pyrimethamine drug combination
Pyrimethamine
Sulfadoxine